GEHC 870 DR Technology Image 1 v1
technology

Full spectrum of SPECT/CT capability

A fully digital vision for nuclear medicine

  • Provide shorter, more tolerable exams for greater patient comfort with Evolution technology4
  • Up to 50 percent reduction in injected dose or scan time with Evolution technology4
  • Provide shorter, more tolerable exams for greater patient comfort with Evolution technology4
  • Up to 50 percent reduction in injected dose or scan time with Evolution technology4
Future-Ready Image
future-ready

A system that’s ready for the future when you are

  • Cost-effective access to future innovation
  • Pursue improved clinical, operational and economic outcomes with a system ready to leverage advancements in digital solutions
  • Digital-detection-ready platform secures your investment with an easy upgrade path to NM/CT 870 CZT to deliver a whole new level of capability and performance with CZT technology
  • Modular system design allows you to upgrade your system without having to do a complete system swap
Patient Experience Image
patient experience

Make the most of their time

  • Streamlined exam setup leaves you with more time to interact with your patient while increasing throughput

An evolution in SPECT dose management

  • Provide shorter, more tolerable exams for greater patient comfort with Evolution technology4
  • Up to 50 percent reduction in injected dose or scan time with Evolution technology4

Innovative CT dose reduction technology

  • Enhance patient satisfaction with ASiR4 and VISR5, which help achieve your low-dose CT needs
  • Maintain quantitative SPECT accuracy when corrected by low-dose CT with Q.AC6
GEHC 870 DR Quantitation Image 1 v1
quantitation

Quantitative SPECT/CT for every patient, every day

  • Guide therapy planning decisions with quantitative disease state and treatment response assessments
  • Grow patient volumes with referring physicians that value accurate, reproducible results and the diagnostic confidence you deliver

Built for quantitation

GEHC 870 DR Quantitative Applications Image 1 v1
quantitative applications

Inform your decisions with measurable results

  • Q. Volumetrix MI

    Q.Volumetrix MI enables routine quantitative SPECT results in the form of MBq/ml and SPECT SUV without workflow impediments for both base line and longitudinal studies.

  • Q. Volumetrix MI

    Q.Volumetrix MI integrates SUV measurements directly into the volume viewer, so you can see both results in the same application.

  • Q. Brain

    Accurately diagnose neurodegenerative diseases with Q.Brain.

  • DaTQUANT™

    Improve neurologic SPECT workflow with fast, reproducible and accurate quantitation of 123I Ioflupane with DaTQUANT.

  • Q. Lung

    Diagnose pulmonary embolism by identifying V/Q mismatch with Q.Lung.

  • Q. Lung

    Confidently classify patients eligible for lung resection surgeries with Q.Lung.

  • Dosimetry Toolkit

    Plan radioisotope therapy by measuring changes in tracer absorption over time with Dosimetry Toolkit.

GEHC 870 DR Summary Image 1 v1
summary

A SPECT/CT system for true discovery

Related Products

  • 1 Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/ dose for the particular clinical task.
  • 2 Image quality as defined by an Artifact Index in Phantom testing. Data on file.
  • 3 As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
  • 4 In clinical practice, Evolution options4a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit4b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
  • 4a Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
  • 4b Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
  • 5 In clinical practice, the use of ASiR or VISR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
  • 6 Quantitative accuracy defined as equivalence to well counter-measured injected activity in a test phantom. Equivalence means <11% difference when comparing measured counts in SPECT studies corrected by Q.AC-reconstructed CTAC to measured counts in studies corrected by benchmark reconstructed CTAC. Measured counts are defined as average within identical ROIs positioned on SPECT reconstructed slices of homogenous 99mTc solution phantom study.

JB55598XX(1)